Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

Clinical trial NCT00511238 · COMPLETED

Trial details

NCT number: NCT00511238
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2007-08-01
Primary completion: 2010-11-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.